Global Botulinum Toxin Market Insights, Forecast to 2026

Published On: March 2020 | Report ID: 196192 | Category: Pharmaceuticals and HealthcarePages: 119

Botulinum toxin (BTX) or Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.

The major growth drivers for the botulinum toxin market are: aging population, escalating numbers of surgeons, upsurge in facial aesthetics procedures, rising alternative of non-surgical procedures, increasing healthcare spending in emerging markets. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as potential health risk associated with botulinum toxin and botulinum toxins as bio-terror threat.

The Americas accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. Some of the major factors responsible for the market's growth in the region is the approval for new indications and the inorganic growth strategies of vendors.

The global Botulinum Toxin market is valued at xx million US$ in 2020 and will reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2020-2026. The objectives of this study are to define, segment, and project the size of the Botulinum Toxin market based on company, product type, end user and key regions.

This report studies the global market size of Botulinum Toxin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Botulinum Toxin in these regions.

This research report categorizes the global Botulinum Toxin market by top players/brands, region, type and end user. This report also studies the global Botulinum Toxin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

ALLERGAN

Galderma

Merz Pharma

DAEWOONG

Market size by Product

Botulinum Toxin Type A

Botulinum Toxin Type B

Others

Market size by End User

Cosmetic Applications

Therapeutic Applications

Market size by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Botulinum Toxin market size (value & volume) by company, key regions, products and end user, breakdown data from 2015 to 2019, and forecast to 2026.

To understand the structure of Botulinum Toxin market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Botulinum Toxin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Botulinum Toxin submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Botulinum Toxin are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Botulinum Toxin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Botulinum Toxin Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Botulinum Toxin Market Size Growth Rate by Product

1.4.2 Botulinum Toxin Type A

1.4.3 Botulinum Toxin Type B

1.4.4 Others

1.5 Market by End User

1.5.1 Global Botulinum Toxin Market Size Growth Rate by End User

1.5.2 Cosmetic Applications

1.5.3 Therapeutic Applications

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Botulinum Toxin Market Size

2.1.1 Global Botulinum Toxin Revenue 2015-2026

2.1.2 Global Botulinum Toxin Sales 2015-2026

2.2 Botulinum Toxin Growth Rate by Regions

2.2.1 Global Botulinum Toxin Sales by Regions

2.2.2 Global Botulinum Toxin Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Botulinum Toxin Sales by Manufacturers

3.1.1 Botulinum Toxin Sales by Manufacturers

3.1.2 Botulinum Toxin Sales Market Share by Manufacturers

3.1.3 Global Botulinum Toxin Market Concentration Ratio (CR5 and HHI)

3.2 Botulinum Toxin Revenue by Manufacturers

3.2.1 Botulinum Toxin Revenue by Manufacturers (2015-2020)

3.2.2 Botulinum Toxin Revenue Share by Manufacturers (2015-2020)

3.3 Botulinum Toxin Price by Manufacturers

3.4 Botulinum Toxin Manufacturing Base Distribution, Product Types

3.4.1 Botulinum Toxin Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Botulinum Toxin Product Type

3.4.3 Date of International Manufacturers Enter into Botulinum Toxin Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Botulinum Toxin Sales by Product

4.2 Global Botulinum Toxin Revenue by Product

4.3 Botulinum Toxin Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Botulinum Toxin Breakdown Data by End User

6 North America

6.1 North America Botulinum Toxin by Countries

6.1.1 North America Botulinum Toxin Sales by Countries

6.1.2 North America Botulinum Toxin Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Botulinum Toxin by Product

6.3 North America Botulinum Toxin by End User

7 Europe

7.1 Europe Botulinum Toxin by Countries

7.1.1 Europe Botulinum Toxin Sales by Countries

7.1.2 Europe Botulinum Toxin Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Botulinum Toxin by Product

7.3 Europe Botulinum Toxin by End User

8 Asia Pacific

8.1 Asia Pacific Botulinum Toxin by Countries

8.1.1 Asia Pacific Botulinum Toxin Sales by Countries

8.1.2 Asia Pacific Botulinum Toxin Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Botulinum Toxin by Product

8.3 Asia Pacific Botulinum Toxin by End User

9 Central & South America

9.1 Central & South America Botulinum Toxin by Countries

9.1.1 Central & South America Botulinum Toxin Sales by Countries

9.1.2 Central & South America Botulinum Toxin Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Botulinum Toxin by Product

9.3 Central & South America Botulinum Toxin by End User

10 Middle East and Africa

10.1 Middle East and Africa Botulinum Toxin by Countries

10.1.1 Middle East and Africa Botulinum Toxin Sales by Countries

10.1.2 Middle East and Africa Botulinum Toxin Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Botulinum Toxin by Product

10.3 Middle East and Africa Botulinum Toxin by End User

11 Company Profiles

11.1 ALLERGAN

11.1.1 ALLERGAN Company Details

11.1.2 Company Business Overview

11.1.3 ALLERGAN Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)

11.1.4 ALLERGAN Botulinum Toxin Products Offered

11.1.5 ALLERGAN Recent Development

11.2 Galderma

11.2.1 Galderma Company Details

11.2.2 Company Business Overview

11.2.3 Galderma Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)

11.2.4 Galderma Botulinum Toxin Products Offered

11.2.5 Galderma Recent Development

11.3 Merz Pharma

11.3.1 Merz Pharma Company Details

11.3.2 Company Business Overview

11.3.3 Merz Pharma Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)

11.3.4 Merz Pharma Botulinum Toxin Products Offered

11.3.5 Merz Pharma Recent Development

11.4 DAEWOONG

11.4.1 DAEWOONG Company Details

11.4.2 Company Business Overview

11.4.3 DAEWOONG Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)

11.4.4 DAEWOONG Botulinum Toxin Products Offered

11.4.5 DAEWOONG Recent Development

12 Future Forecast

12.1 Botulinum Toxin Market Forecast by Regions

12.1.1 Global Botulinum Toxin Sales Forecast by Regions 2020-2026

12.1.2 Global Botulinum Toxin Revenue Forecast by Regions 2020-2026

12.2 Botulinum Toxin Market Forecast by Product

12.2.1 Global Botulinum Toxin Sales Forecast by Product 2020-2026

12.2.2 Global Botulinum Toxin Revenue Forecast by Product 2020-2026

12.3 Botulinum Toxin Market Forecast by End User

12.4 North America Botulinum Toxin Forecast

12.5 Europe Botulinum Toxin Forecast

12.6 Asia Pacific Botulinum Toxin Forecast

12.7 Central & South America Botulinum Toxin Forecast

12.8 Middle East and Africa Botulinum Toxin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Botulinum Toxin Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@marketresearchplace.com

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.